aleglitazar
Description: A pharmacological compound that activates both PPARα and PPARγ receptors and has been investigated for treating metabolic and cardiovascular disorders.
Primary topic: Peroxisome Proliferator-Activated Receptors (49%)
Wikidata ID: wiki/Q3609417
OpenAlex ID: keywords/aleglitazar
